These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 24145358)

  • 1. Listeria monocytogenes (Lm)-LLO immunotherapies reduce the immunosuppressive activity of myeloid-derived suppressor cells and regulatory T cells in the tumor microenvironment.
    Wallecha A; Singh R; Malinina I
    J Immunother; 2013; 36(9):468-76. PubMed ID: 24145358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity of murine solid tumor models as a defining feature of in vivo behavior and response to immunotherapy.
    Lechner MG; Karimi SS; Barry-Holson K; Angell TE; Murphy KA; Church CH; Ohlfest JR; Hu P; Epstein AL
    J Immunother; 2013; 36(9):477-89. PubMed ID: 24145359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory T cells and myeloid-derived suppressor cells in the tumor microenvironment undergo Fas-dependent cell death during IL-2/αCD40 therapy.
    Weiss JM; Subleski JJ; Back T; Chen X; Watkins SK; Yagita H; Sayers TJ; Murphy WJ; Wiltrout RH
    J Immunol; 2014 Jun; 192(12):5821-9. PubMed ID: 24808361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant Listeria vaccines containing PEST sequences are potent immune adjuvants for the tumor-associated antigen human papillomavirus-16 E7.
    Sewell DA; Shahabi V; Gunn GR; Pan ZK; Dominiecki ME; Paterson Y
    Cancer Res; 2004 Dec; 64(24):8821-5. PubMed ID: 15604239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activated T cells sustain myeloid-derived suppressor cell-mediated immune suppression.
    Pinton L; Solito S; Damuzzo V; Francescato S; Pozzuoli A; Berizzi A; Mocellin S; Rossi CR; Bronte V; Mandruzzato S
    Oncotarget; 2016 Jan; 7(2):1168-84. PubMed ID: 26700461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer-associated fibroblast-targeted strategy enhances antitumor immune responses in dendritic cell-based vaccine.
    Ohshio Y; Teramoto K; Hanaoka J; Tezuka N; Itoh Y; Asai T; Daigo Y; Ogasawara K
    Cancer Sci; 2015 Feb; 106(2):134-42. PubMed ID: 25483888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High efficacy of a Listeria-based vaccine against metastatic breast cancer reveals a dual mode of action.
    Kim SH; Castro F; Paterson Y; Gravekamp C
    Cancer Res; 2009 Jul; 69(14):5860-6. PubMed ID: 19584282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agonist anti-GITR antibody significantly enhances the therapeutic efficacy of Listeria monocytogenes-based immunotherapy.
    Shrimali R; Ahmad S; Berrong Z; Okoev G; Matevosyan A; Razavi GSE; Petit R; Gupta S; Mkrtichyan M; Khleif SN
    J Immunother Cancer; 2017 Aug; 5(1):64. PubMed ID: 28807056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant properties of listeriolysin O protein in a DNA vaccination strategy.
    Peng X; Treml J; Paterson Y
    Cancer Immunol Immunother; 2007 Jun; 56(6):797-806. PubMed ID: 17102978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4+CD25+ regulatory T cells that secrete TGFbeta and IL-10 are preferentially induced by a vaccine vector.
    Hussain SF; Paterson Y
    J Immunother; 2004; 27(5):339-46. PubMed ID: 15314542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Listeriolysin O, a cytolysin derived from Listeria monocytogenes, inhibits generation of ovalbumin-specific Th2 immune response by skewing maturation of antigen-specific T cells into Th1 cells.
    Yamamoto K; Kawamura I; Tominaga T; Nomura T; Kohda C; Ito J; Mitsuyama M
    Clin Exp Immunol; 2005 Nov; 142(2):268-74. PubMed ID: 16232213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucosal vaccine using CTL epitope-pulsed dendritic cell confers protection for intracellular pathogen.
    Ozawa Y; Suda T; Nagata T; Hashimoto D; Nakamura Y; Enomoto N; Inui N; Koide Y; Nakamura H; Chida K
    Am J Respir Cell Mol Biol; 2009 Oct; 41(4):440-8. PubMed ID: 19202004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poxvirus-based active immunotherapy synergizes with CTLA-4 blockade to increase survival in a murine tumor model by improving the magnitude and quality of cytotoxic T cells.
    Foy SP; Mandl SJ; dela Cruz T; Cote JJ; Gordon EJ; Trent E; Delcayre A; Breitmeyer J; Franzusoff A; Rountree RB
    Cancer Immunol Immunother; 2016 May; 65(5):537-49. PubMed ID: 26961085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a Listeria monocytogenes based vaccine against prostate cancer.
    Shahabi V; Reyes-Reyes M; Wallecha A; Rivera S; Paterson Y; Maciag P
    Cancer Immunol Immunother; 2008 Sep; 57(9):1301-13. PubMed ID: 18273616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteopontin shapes immunosuppression in the metastatic niche.
    Sangaletti S; Tripodo C; Sandri S; Torselli I; Vitali C; Ratti C; Botti L; Burocchi A; Porcasi R; Tomirotti A; Colombo MP; Chiodoni C
    Cancer Res; 2014 Sep; 74(17):4706-19. PubMed ID: 25035397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic Regulation of Tregs in Cancer: Opportunities for Immunotherapy.
    Wang H; Franco F; Ho PC
    Trends Cancer; 2017 Aug; 3(8):583-592. PubMed ID: 28780935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Listeria monocytogenes induces T cell receptor unresponsiveness through pore-forming toxin listeriolysin O.
    Gekara NO; Zietara N; Geffers R; Weiss S
    J Infect Dis; 2010 Dec; 202(11):1698-707. PubMed ID: 20961225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting CCR8 Induces Protective Antitumor Immunity and Enhances Vaccine-Induced Responses in Colon Cancer.
    Villarreal DO; L'Huillier A; Armington S; Mottershead C; Filippova EV; Coder BD; Petit RG; Princiotta MF
    Cancer Res; 2018 Sep; 78(18):5340-5348. PubMed ID: 30026324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Episomal expression of truncated listeriolysin O in LmddA-LLO-E7 vaccine enhances antitumor efficacy by preferentially inducing expansions of CD4+FoxP3- and CD8+ T cells.
    Chen Z; Ozbun L; Chong N; Wallecha A; Berzofsky JA; Khleif SN
    Cancer Immunol Res; 2014 Sep; 2(9):911-22. PubMed ID: 24872025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-PD-1 antibody significantly increases therapeutic efficacy of Listeria monocytogenes (Lm)-LLO immunotherapy.
    Mkrtichyan M; Chong N; Abu Eid R; Wallecha A; Singh R; Rothman J; Khleif SN
    J Immunother Cancer; 2013; 1():15. PubMed ID: 24829751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.